Horizon Therapeutics Common
|
15.6 |
$986M |
|
9.0M |
109.54 |
Mirati Therapeutics Common
|
14.0 |
$885M |
|
5.0M |
176.91 |
Acceleron Pharma Common
|
12.2 |
$770M |
|
4.5M |
172.10 |
United Therapeutics Corp Common
(UTHR)
|
8.8 |
$554M |
|
3.0M |
184.58 |
Ascendis Pharma Sponsored ADR
(ASND)
|
5.0 |
$316M |
|
2.0M |
159.39 |
Argenx Se Sponsored ADR
(ARGX)
|
4.5 |
$286M |
|
947k |
302.00 |
Sarepta Therapeutics Common
(SRPT)
|
4.0 |
$250M |
|
2.7M |
92.48 |
Apellis Pharmaceuticals Common
(APLS)
|
3.4 |
$215M |
|
6.5M |
32.96 |
Arena Pharmaceuticals Common
|
3.2 |
$204M |
|
3.4M |
59.55 |
Amicus Therapeutics Common
(FOLD)
|
2.7 |
$169M |
|
18M |
9.55 |
Alnylam Pharmaceuticals Common
(ALNY)
|
2.5 |
$161M |
|
850k |
188.81 |
Biomarin Pharmaceutical Common
(BMRN)
|
2.3 |
$145M |
|
1.9M |
77.29 |
Vertex Pharmaceuticals Common
(VRTX)
|
1.9 |
$120M |
|
664k |
181.39 |
Iveric Bio Common
|
1.8 |
$115M |
|
7.1M |
16.24 |
Madrigal Pharmaceuticals Common
(MDGL)
|
1.8 |
$114M |
|
1.4M |
79.79 |
Trillium Therapeutics Common
|
1.6 |
$100M |
|
5.7M |
17.56 |
Pmv Pharmaceuticals Common
(PMVP)
|
1.4 |
$87M |
|
2.9M |
29.80 |
Kura Oncology Common
(KURA)
|
1.2 |
$75M |
|
4.0M |
18.73 |
Mersana Therapeutics Common
(MRSN)
|
1.0 |
$64M |
|
6.8M |
9.43 |
Monte Rosa Therapeutics Common
(GLUE)
|
1.0 |
$61M |
|
3.3M |
18.42 |
Xenon Pharmaceuticals Common
(XENE)
|
0.9 |
$56M |
|
3.7M |
15.28 |
Aadi Biosciences Common
(AADI)
|
0.9 |
$54M |
|
1.8M |
29.37 |
Mannkind Corp Common
(MNKD)
|
0.6 |
$38M |
|
8.8M |
4.35 |
Cymabay Therapeutics Common
|
0.6 |
$38M |
|
10M |
3.65 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.6 |
$37M |
|
3.2M |
11.38 |
Acadia Pharmaceuticals Common
(ACAD)
|
0.6 |
$37M |
|
2.2M |
16.61 |
Deciphera Pharmaceuticals Common
|
0.6 |
$36M |
|
1.1M |
33.98 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.5 |
$31M |
|
6.0M |
5.10 |
Praxis Precision Medicines Common
|
0.5 |
$30M |
|
1.6M |
18.49 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.5 |
$30M |
|
1.5M |
19.11 |
Avidity Biosciences Common
(RNA)
|
0.4 |
$28M |
|
1.2M |
24.63 |
Kymera Therapeutics Common
(KYMR)
|
0.4 |
$27M |
|
456k |
58.74 |
Dice Therapeutics Common
|
0.4 |
$26M |
|
800k |
32.75 |
Biogen Common
(BIIB)
|
0.4 |
$24M |
|
84k |
282.99 |
Avadel Pharmaceuticals Sponsored ADR
|
0.4 |
$22M |
|
2.3M |
9.80 |
Nuvalent Common
(NUVL)
|
0.4 |
$22M |
|
1.3M |
17.72 |
Design Therapeutics Common
(DSGN)
|
0.3 |
$22M |
|
1.5M |
14.69 |
Tango Therapeutics Common
(TNGX)
|
0.3 |
$20M |
|
1.6M |
12.93 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$16M |
|
1.7M |
9.42 |
Iovance Biotherapeutics Common Call Option
(IOVA)
|
0.2 |
$16M |
|
9.2M |
1.70 |
Adverum Biotechnologies Common
|
0.2 |
$15M |
|
7.0M |
2.17 |
Merus N V Common
(MRUS)
|
0.2 |
$9.9M |
|
450k |
22.00 |
Genocea Biosciences Common
(GNCAQ)
|
0.2 |
$9.8M |
|
5.1M |
1.92 |